VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease
Clinical trial NCT06874621 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06874621
- Sponsor
- Voyager Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-03
- Primary completion
- 2027-05-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.